MedTrace Logo

Component and Couple Analysis of Cancer Communications

NCT00468741 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 338

Last updated 2019-11-18

No results posted yet for this study

Summary

Component and Couple Analysis of Cancer Communication

CHESS, the Comprehensive Health Enhancement Support System is an innovative technology that provides information, social support and skills training to women with breast cancer. Previous CHESS clinical trials found improved patient outcomes but little is known about what services in CHESS produce those results. This study will examine whether breast cancer patient outcomes change when conceptually distinct CHESS services (information, social support, and skills training) are systematically added to a patients treatment resources.

Primary Aims:

* Determine the relative efficacies of different types of cancer communication treatments when they are presented alone or in combination
* Determine routes or processes via which these elements work
* Determine for whom the different treatment types work best.

Conditions

Interventions

BEHAVIORAL

CHESS (Comprehensive Health Enhancement Support System)

Full CHESS for subject use

BEHAVIORAL

CHESS

informational services of CHESS available to subject

BEHAVIORAL

CHESS

CHESS informational services and social support available to subject

Sponsors & Collaborators

  • National Cancer Institute (NCI)

    collaborator NIH

  • University of Wisconsin, Madison

    lead OTHER

Principal Investigators

  • Timothy Baker, PhD · University of Wisconsin, Madison

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2003-09-30
Primary Completion
2008-12-31
Completion
2014-06-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00468741 on ClinicalTrials.gov